Workup for Foot Numbness in Diabetic Patients
For a diabetic patient presenting with foot numbness, perform a comprehensive foot examination including 10-g monofilament testing plus at least one additional neurological test (pinprick, temperature, vibration with 128-Hz tuning fork, or ankle reflexes), along with vascular assessment including pedal pulse palpation and evaluation for peripheral arterial disease. 1, 2
Initial Clinical Assessment
History Taking
Obtain specific information about:
- Prior ulceration, amputation, or Charcot foot 3, 1, 2
- Vascular history: angioplasty, vascular surgery, symptoms of claudication (leg fatigue with walking), or rest pain 3, 1, 2
- Smoking status - a critical modifiable risk factor 3, 1
- Other microvascular complications: retinopathy and chronic kidney disease (especially dialysis patients) 3, 2
- Current neuropathic symptoms: pain, burning sensations, or numbness 3, 1, 2
Physical Examination Components
Neurological Assessment (to identify loss of protective sensation):
- 10-g Semmes-Weinstein monofilament testing - the single most useful screening tool 1, 2, 4
- Plus at least one additional test: pinprick sensation (dorsum of foot), temperature perception, vibration with 128-Hz tuning fork, or ankle reflexes 3, 1, 2, 5
- Interpretation: Absent monofilament sensation suggests loss of protective sensation; at least two normal tests with no abnormal tests rules it out 3, 1, 4
Vascular Assessment:
- Palpate dorsalis pedis and posterior tibial pulses 5, 2
- Assess capillary refill time, rubor on dependency, pallor on elevation, and venous filling time 2, 4
- If claudication symptoms or decreased/absent pulses are present: refer for ankle-brachial index (ABI) testing 3, 1, 2, 4
- Note: In diabetic patients or those with renal insufficiency who have ABI >1.40 (falsely elevated due to calcified vessels), obtain toe-brachial index instead 4
Skin and Structural Assessment:
- Inspect for: calluses, color changes, temperature differences, edema, pre-ulcerative signs 3, 5
- Assess for foot deformities: hammertoes, claw toes, prominent metatarsal heads, bunions, Charcot foot 3, 1, 5
- Evaluate footwear: inspect both inside and outside of shoes and socks 5
Laboratory Workup
Essential initial tests:
- HbA1c - to assess glycemic control, as optimal control can prevent and slow neuropathy progression 2, 4
- Serum creatinine and estimated glomerular filtration rate (eGFR) - renal insufficiency increases neuropathy and foot complication risk 4
Additional testing if neuropathy is atypical or diagnosis uncertain 6:
- Complete blood count
- Comprehensive metabolic profile
- Fasting blood glucose (if not already diabetic)
- Vitamin B12 level
- Thyroid-stimulating hormone
- Serum protein electrophoresis with immunofixation
When to consider electrodiagnostic studies: Reserve for atypical presentations or when clinical features don't fit typical diabetic peripheral neuropathy 2, 6
Risk Stratification and Follow-up Frequency
Based on the International Working Group on the Diabetic Foot classification 5:
- Category 0 (no neuropathy): Annual screening 5
- Category 1 (peripheral neuropathy present): Every 6 months 5
- Category 2 (neuropathy + PAD and/or foot deformity): Every 3-6 months 5
- Category 3 (neuropathy + history of ulcer/amputation): Every 1-3 months 5
Patients with evidence of sensory loss or prior ulceration should have feet inspected at every visit 3, 1, 2
Referral Indications
Immediate referral to foot care specialist for:
- History of prior lower-extremity ulcers or amputations 1, 2
- Loss of protective sensation with structural abnormalities 1, 2
- Peripheral arterial disease 1, 2
- Active smoking with any of the above risk factors 1, 2
Vascular surgery referral for:
Neurology referral: Only when clinical features are atypical or suggest non-diabetic etiology 2, 6
Critical Pitfalls to Avoid
- Don't assume all foot numbness in diabetics is from peripheral neuropathy - up to 25-46% of peripheral neuropathy cases are idiopathic, and other treatable causes must be excluded 6
- Don't miss peripheral arterial disease - up to 50% of diabetic foot ulcer patients have PAD, and many are asymptomatic due to neuropathy 5, 7
- Don't rely on symptoms alone - up to 50% of diabetic peripheral neuropathy is asymptomatic, requiring objective testing 2
- Don't overlook the acute red, hot, swollen foot - this requires immediate workup to exclude Charcot neuroarthropathy 1
- Neuropathy screening identifies high-risk patients - those with both neuropathy and PAD have significantly increased risk of amputation, revascularization, and death (hazard ratio 3.19) 7